Health Care Sector
831 health care stocks ranked by market capitalization. Updated November 22, 2026.
The Health Care sector includes 1,017 US-listed stocks tracked by MetaCap with a combined market capitalization of $9.25T. As of November 22, 2026, the sector is down 0.41% on the day, based on the XLV sector ETF, outperforming the S&P 500 (-3.70%). The largest companies are Eli Lilly (LLY) at $1.2T, Johnson & Johnson (JNJ) at $651.1B and AbbVie (ABBV) at $505.9B, together 25.5% of the sector's value. Among the companies on this page, 18 of 50 are higher today; HCA Healthcare (HCA) is the best performer (+3.31%) and Natera (NTRA) the weakest (-5.70%).
Summary generated from market data by MetaCap's automated system. Methodology
Largest health care stocks by market cap
| # | Symbol | Company | Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1,347.11 | -0.30% | 3.54M | $1.20T |
| 2 | JNJ | Johnson & Johnson | 270.47 | +1.25% | 11.92M | $651.11B |
| 3 | ABBV | AbbVie Inc. | 286.20 | +0.94% | 8.76M | $505.89B |
| 4 | MRK | Merck & Company Inc. | 133.72 | +0.69% | 15.61M | $329.65B |
| 5 | UNH | UnitedHealth Group Incorporated | 339.85 | +2.84% | 12.77M | $304.51B |
| 6 | PM | Philip Morris International Inc | 184.09 | -1.26% | 9.58M | $286.93B |
| 7 | NVS | Novartis AG | 150.47 | -0.50% | 2.24M | $284.18B |
| 8 | AZN | AstraZeneca PLC | 174.35 | -0.60% | 2.02M | $270.40B |
| 9 | AMGN | Amgen Inc. | 435.64 | -0.15% | 4.94M | $235.64B |
| 10 | GILD | Gilead Sciences Inc. | 166.43 | -0.06% | 7.56M | $206.43B |
| 11 | ABT | Abbott Laboratories | 103.00 | -0.84% | 7.29M | $178.39B |
| 12 | NVO | Novo Nordisk A/S | 37.82 | -2.70% | 13.04M | $166.69B |
| 13 | PFE | Pfizer Inc. | 27.40 | -0.51% | 38.29M | $156.18B |
| 14 | ISRG | Intuitive Surgical Inc. | 399.05 | -2.01% | 2.69M | $138.33B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 515.02 | -1.08% | 1.77M | $130.58B |
| 16 | MDT | Medtronic plc. | 99.94 | -0.67% | 9.03M | $127.84B |
| 17 | MO | Altria Group Inc. | 74.87 | +0.25% | 10.29M | $124.54B |
| 18 | MCK | McKesson Corporation | 1,069.43 | +0.68% | 869.45K | $123.47B |
| 19 | BTI | British American Tobacco Industries p.l.c. | 56.84 | -1.10% | 3.38M | $122.06B |
| 20 | BMY | Bristol-Myers Squibb Company | 58.80 | +0.79% | 12.63M | $120.19B |
| 21 | SYK | Stryker Corporation | 310.00 | -0.98% | 2.38M | $118.01B |
| 22 | SNY | Sanofi ADS | 46.52 | +1.00% | 4.29M | $111.70B |
| 23 | HCA | HCA Healthcare Inc. | 475.57 | +3.31% | 1.58M | $99.34B |
| 24 | GSK | GSK plc ADR | 47.76 | -0.13% | 2.74M | $95.73B |
| 25 | REGN | Regeneron Pharmaceuticals Inc. | 920.69 | -0.19% | 877.67K | $95.24B |
| 26 | MMM | 3M Company | 177.99 | -0.27% | 5.65M | $91.97B |
| 27 | ELV | Elevance Health Inc. | 394.48 | +1.11% | 2.04M | $85.23B |
| 28 | MRNA | Moderna Inc. | 195.00 | -2.17% | 9.66M | $78.90B |
| 29 | CI | The Cigna Group | 270.90 | -0.78% | 2.62M | $71.38B |
| 30 | TAK | Takeda Pharmaceutical Company Limited ADR | 21.77 | +1.68% | 3.80M | $69.55B |
| 31 | COR | Cencora Inc. | 339.09 | -0.63% | 1.23M | $64.71B |
| 32 | CAH | Cardinal Health Inc. | 272.81 | +0.17% | 1.98M | $63.06B |
| 33 | BSX | Boston Scientific Corporation | 41.98 | -2.35% | 15.22M | $60.85B |
| 34 | EW | Edwards Lifesciences Corporation | 101.85 | -1.95% | 3.62M | $58.56B |
| 35 | ARGX | argenx SE ADR | 925.70 | -1.73% | 249.72K | $58.21B |
| 36 | BDX | Becton Dickinson and Company | 212.78 | +0.05% | 1.96M | $57.96B |
| 37 | IDXX | IDEXX Laboratories Inc. | 676.21 | -1.95% | 614.30K | $53.28B |
| 38 | MDLN | Medline Inc. Class A | 37.04 | -2.11% | 9.33M | $48.75B |
| 39 | HUM | Humana Inc. | 390.00 | +2.63% | 2.31M | $46.84B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 39.23 | +1.79% | 6.81M | $45.77B |
| 41 | ONC | BeOne Medicines Ltd. ADR | 390.94 | -2.19% | 356.78K | $44.66B |
| 42 | IQV | IQVIA Holdings Inc. | 245.82 | -1.89% | 1.25M | $40.51B |
| 43 | NTRA | Natera Inc. | 273.40 | -5.70% | 1.38M | $39.64B |
| 44 | RPRX | Royalty Pharma plc Class A | 68.45 | +1.08% | 3.53M | $39.36B |
| 45 | BIIB | Biogen Inc. | 249.59 | +1.00% | 1.13M | $36.89B |
| 46 | GEHC | GE HealthCare Technologies Inc. | 80.64 | -1.53% | 3.77M | $36.46B |
| 47 | ALC | Alcon Inc. | 74.31 | -0.26% | 3.42M | $35.70B |
| 48 | RVMD | Revolution Medicines Inc. | 161.20 | +1.11% | 4.74M | $34.87B |
| 49 | RMD | ResMed Inc. | 235.63 | -0.53% | 1.37M | $33.14B |
| 50 | ZTS | Zoetis Inc. Class A | 79.11 | -2.08% | 6.10M | $32.14B |
Frequently asked questions
- How many health care stocks are there?
- MetaCap tracks 831 US-listed stocks in the Health Care sector, worth a combined $9.25T.
- What is the largest health care company?
- Eli Lilly (LLY) is the largest health care stock by market capitalization, at about $1.20T.
- What ETF tracks the health care sector?
- XLV is the Select Sector SPDR fund for Health Care, and MetaCap uses it as the benchmark for the sector's daily performance. Other providers, such as Vanguard and iShares, offer similar sector funds.
- How is the health care sector doing today?
- As of November 22, 2026, the Health Care sector is down 0.41% based on XLV.
Prices as of Nov 22, 9:10 AM EST. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer